Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

AHA Scientific Sessions 2022 Late-Breaking Science Coverage

Published: 02 November 2022

Views:
5428
Likes:
7

Views:
5428
Likes:
7
Share:

Now Playing
Part 5 | Session 1 of 4
Being a Researcher With Investigator, Dr Julian Gillmore
Julian Gillmore

Up Next
56s

Part 5 | Session 2 Research in 2022 With Investigator, Dr Shino Kany
Shino Kany
3m 1s

Part 5 | Session 3 Making a Difference With Physician-Scientist, Dr Schlaich
Markus P Schlaich
2m 51s

Part 5 | Session 4 What Makes Dr Bonaca excited about CV Science in 2022?
Marc P Bonaca

5m 44s

Part 6 | Session 1 Late-breaking Science Highlights With Dr Joseph A Hill
Joseph A Hill
12m 38s

Part 6 | Session 2 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag
Mirvat Alasnag

35m 25s

Part 1 | Session 1 What's Hot at AHA22? Late-Breaking Science Wrap-up Nicolas M Van Mieghem, Joost Daemen

15m 30s

Part 1 | Session 2 What's Hot at AHA22? Late-Breaking Science Preview Nicolas M Van Mieghem, Joost Daemen

13m 29s

Part 2 | Session 1 The TRANSFORM-HF Trial WIth Dr Van Spall & Dr Mentz Robert Mentz, Harriette Van Spall

21m 14s

Part 2 | Session 2 The STRONG-HF Trial With Dr Van Spall & Prof Mebazaa Alexandre Mebazaa, Harriette Van Spall

14m 56s

Part 2 | Session 3 The PRECISE Trial With Dr Van Spall & Dr Douglas Pamela S Douglas, Harriette Van Spall

8m 12s

Part 3 | Session 1 CRISPR-Cas9 In Vivo Gene Editing in Pts With ATTR Amyloidosis With Cardiomyopathy Julian Gillmore

5m 39s

Part 3 | Session 2 EAST-AFNET4: Rhythm Control Therapy in Atrial Fibrillation Shino Kany

7m 23s

Part 3 | Session 3 BT001 PIVOTAL: nCBT in Pts with Type II Diabetes Marc P Bonaca

8m 38s

Part 3 | Session 4 PRECISION: Aprocitentan in the Treatment of Resistant Hypertension Markus P Schlaich

9m 16s

Part 3 | Session 5 NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation Jonathan Piccini

5m

Part 3 | Session 6 EMPEROR-POOLED: Clinical Outcomes & Efficacy of Empagliflozin in Black vs White Pts With HF Subodh Verma

10m 6s

Part 3 | Session 7 SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension David Kandzari

14m 20s

Part 4 | Session 1 The PROMINENT Trial With Dr Kaur & Dr Pradhan Aruna D Pradhan, Gurleen Kaur

14m 28s

Part 4 | Session 2 The OCEAN(a)-DOSE Trial With Dr Gurleen Kaur & Dr Michelle L O'Donoghue Gurleen Kaur, Michelle O'Donoghue

18m 1s

Part 4 | Session 3 The EMPA-Kidney Trial With Dr Wilcox & Dr Preiss David Preiss, Kate Wilcox

15m 37s

Part 4 | Session 4 The PREVENT-HD Randomized Clinical Trial With Dr Fadah & Dr Piazza Gregory Piazza, Kahtan Fadah

14m 14s

Part 4 | Session 5 The RESPECT EPA Trial With Prof Daida & Dr Jumkhawala Saahil A Jumkhawala, Hiroyuki Daida

13m 6s

Part 4 | Session 6 The PROGRESSIVE-AF Trial With Dr Wilcox & Dr Andrade Jason G Andrade, Kate Wilcox

13m 45s

Part 4 | Session 7 The ECMO-CS Trial With Dr Ostadal & Dr Jumkhawala Petr Ostadal, Saahil A Jumkhawala

18m 58s

Part 4 | Session 8 The IRONMAN Trial With Dr Amir & Dr Kalra Rawan Amir, Paul Kalra

Average (ratings)

No ratings

Your rating

Overview

Stay updated with the latest data in cardiovascular science with the help of recognised experts and new voices offering practical summaries, in-depth discussions and critical reviews.

With their fingers on the pulse of cardiovascular innovation, Prof Van Mieghem and Dr Daemen offer their succinct and insightful take on the most expected trials of AHA 22 in their regular review series View from the Thoraxcenter.

Dr Harriette Van Spall, recipient of this year’s AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they talk about methodology, results, and impact on patient care.

This year we partner with @CardioNerds to bring the fresh perspective of a great team founded to democratize cardiovascular education. Get the most of the new data from an interview series featuring principal investigators and trainees from the CardioNerds family.

Look behind the scientific achievement and learn more about the personal motivations of some of the investigators, benefit from their advice for early career researchers through our Behind the Heart series.

More from this programme

Part 1

View from the Thoraxcenter: Review Series

In this dynamic late-breaking science preview Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of the AHA Scientific Sessions.

2 sessions
What's Hot at AHA22? Late-Breaking Science Wrap-up	Watch now
What's Hot at AHA22? Late-Breaking Science Preview	Watch now

Part 2

Late-breaker Discussions With Harriette Van Spall

Dr Harriette Van Spall, recipient of this year’s AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they talk about methodology, results, and impact on patient care.

3 sessions
The TRANSFORM-HF Trial WIth Dr Van Spall & Dr Mentz	Watch now
The STRONG-HF Trial With Dr Van Spall & Prof Mebazaa	Watch now
The PRECISE Trial With Dr Van Spall & Dr Douglas	Watch now

Part 3

Expert Interviews

Late-breaking science methodology, results and implications for practice and research under 10 minutes.

7 sessions
CRISPR-Cas9 In Vivo Gene Editing in Pts With ATTR Amyloidosis With Cardiomyopathy	Watch now
EAST-AFNET4: Rhythm Control Therapy in Atrial Fibrillation	Watch now
BT001 PIVOTAL: nCBT in Pts with Type II Diabetes	Watch now
PRECISION: Aprocitentan in the Treatment of Resistant Hypertension	Watch now
NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation	Watch now
EMPEROR-POOLED: Clinical Outcomes & Efficacy of Empagliflozin in Black vs White Pts With HF	Watch now
SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension	Watch now

Part 4

Radcliffe & CardioNerds @AHA22

This year we partner with @CardioNerds to bring the fresh perspective of a great team founded to democratize cardiovascular education. Get the most of the new data from an interview series featuring principal investigators and trainees from the CardioNerds family.

8 sessions
The PROMINENT Trial With Dr Kaur & Dr Pradhan	Watch now
The OCEAN(a)-DOSE Trial With Dr Gurleen Kaur & Dr Michelle L O'Donoghue	Watch now
The EMPA-Kidney Trial With Dr Wilcox & Dr Preiss	Watch now
The PREVENT-HD Randomized Clinical Trial With Dr Fadah & Dr Piazza	Watch now
The RESPECT EPA Trial With Prof Daida & Dr Jumkhawala	Watch now
The PROGRESSIVE-AF Trial With Dr Wilcox & Dr Andrade	Watch now
The ECMO-CS Trial With Dr Ostadal & Dr Jumkhawala	Watch now
The IRONMAN Trial With Dr Amir & Dr Kalra	Watch now

Part 5

Behind the Heart

4 sessions
Being a Researcher With Investigator, Dr Julian Gillmore	Watch now
Research in 2022 With Investigator, Dr Shino Kany	Watch now
Making a Difference With Physician-Scientist, Dr Schlaich	Watch now
What Makes Dr Bonaca excited about CV Science in 2022?	Watch now

Part 6

AHA22 Highlights

2 sessions
Late-breaking Science Highlights With Dr Joseph A Hill	Watch now
4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag	Watch now

Faculty Biographies

Julian Gillmore

Julian Gillmore

Julian Gillmore gained his medical degree at University of London. He trained in nephrology and undertook MD and PhD degrees in the field of amyloidosis. His research interests include pathogenesis, diagnosis and treatment of amyloidosis.

View full profile